Genetic manipulation of LKB1 elicits lethal metastatic prostate cancerIvana Heřmanová, Arkaitz Carracedo, Rosa Barrio et al.|The Journal of Experimental Medicine|2020Cited by 34
Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, Aleix Prat, Anabel Martínez-Romero et al.|Clinical Cancer Research|2025Cited by 3
Supplementary Data 1 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, A. Prat, Anabel Martínez-Romero et al.|Unknown|2026Cited by 0
Figure 4 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, A. Prat, Anabel Martínez-Romero et al.|Unknown|2026Cited by 0
Figure 3 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, A. Prat, Anabel Martínez-Romero et al.|Unknown|2026Cited by 0